71 related articles for article (PubMed ID: 22890718)
21. Nonhuman primate models for HIV vaccine development.
Letvin NL
Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
[TBL] [Abstract][Full Text] [Related]
22. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H
Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model.
Lipatov AS; Webby RJ; Govorkova EA; Krauss S; Webster RG
J Infect Dis; 2005 Apr; 191(8):1216-20. PubMed ID: 15776365
[TBL] [Abstract][Full Text] [Related]
24. A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccination.
Hoek KL; Samir P; Howard LM; Niu X; Prasad N; Galassie A; Liu Q; Allos TM; Floyd KA; Guo Y; Shyr Y; Levy SE; Joyce S; Edwards KM; Link AJ
PLoS One; 2015; 10(2):e0118528. PubMed ID: 25706537
[TBL] [Abstract][Full Text] [Related]
25. [Progress in new vaccine strategies against influenza: a review].
Liu Z; Jiang T; Qin E; Ran D; Qin C
Sheng Wu Gong Cheng Xue Bao; 2012 May; 28(5):550-6. PubMed ID: 22916493
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice.
Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z
Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721
[TBL] [Abstract][Full Text] [Related]
27. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
Park KS; Seo YB; Lee JY; Im SJ; Seo SH; Song MS; Choi YK; Sung YC
Vaccine; 2011 Jul; 29(33):5481-7. PubMed ID: 21664216
[TBL] [Abstract][Full Text] [Related]
28. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
29. Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
Schmeisser F; Adamo JE; Blumberg B; Friedman R; Muller J; Soto J; Weir JP
Vaccine; 2012 May; 30(23):3413-22. PubMed ID: 22465746
[TBL] [Abstract][Full Text] [Related]
30. Antiretroviral drug studies in nonhuman primates: a valid animal model for innovative drug efficacy and pathogenesis experiments.
Van Rompay KK
AIDS Rev; 2005; 7(2):67-83. PubMed ID: 16092501
[TBL] [Abstract][Full Text] [Related]
31. Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections.
Sun K; Ye J; Perez DR; Metzger DW
J Immunol; 2011 Jan; 186(2):987-93. PubMed ID: 21160043
[TBL] [Abstract][Full Text] [Related]
32. Animal models in influenza vaccine testing.
van der Laan JW; Herberts C; Lambkin-Williams R; Boyers A; Mann AJ; Oxford J
Expert Rev Vaccines; 2008 Aug; 7(6):783-93. PubMed ID: 18665776
[TBL] [Abstract][Full Text] [Related]
33. Influenza pathogenesis: lessons learned from animal studies with H5N1, H1N1 Spanish, and pandemic H1N1 2009 influenza.
Meunier I; Pillet S; Simonsen JN; von Messling V
Crit Care Med; 2010 Apr; 38(4 Suppl):e21-9. PubMed ID: 19935414
[TBL] [Abstract][Full Text] [Related]
34. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
[TBL] [Abstract][Full Text] [Related]
35. Nonhuman primate genetic models for the study of rare diseases.
Vallender EJ; Hotchkiss CE; Lewis AD; Rogers J; Stern JA; Peterson SM; Ferguson B; Sayers K
Orphanet J Rare Dis; 2023 Jan; 18(1):20. PubMed ID: 36721163
[TBL] [Abstract][Full Text] [Related]
36. Utilizing population variation, vaccination, and systems biology to study human immunology.
Tsang JS
Trends Immunol; 2015 Aug; 36(8):479-93. PubMed ID: 26187853
[TBL] [Abstract][Full Text] [Related]
37. Advanced model systems and tools for basic and translational human immunology.
Wagar LE; DiFazio RM; Davis MM
Genome Med; 2018 Sep; 10(1):73. PubMed ID: 30266097
[TBL] [Abstract][Full Text] [Related]
38. Animal Models for Influenza Research: Strengths and Weaknesses.
Nguyen TQ; Rollon R; Choi YK
Viruses; 2021 May; 13(6):. PubMed ID: 34071367
[TBL] [Abstract][Full Text] [Related]
39. Tolerance and dependence to Δ9-tetrahydrocannabinol in rhesus monkeys: Activity assessments.
Wilkerson JL; Schulze DR; McMahon LR
PLoS One; 2019; 14(3):e0209947. PubMed ID: 30861005
[TBL] [Abstract][Full Text] [Related]
40. Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
Itoh Y; Shichinohe S; Nakayama M; Igarashi M; Ishii A; Ishigaki H; Ishida H; Kitagawa N; Sasamura T; Shiohara M; Doi M; Tsuchiya H; Nakamura S; Okamatsu M; Sakoda Y; Kida H; Ogasawara K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4962-73. PubMed ID: 26055368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
